In focus · trending topic

PTCT investor

1 stories · following the connections

Hagens Berman Advises PTC Therapeutics (NASDAQ: PTCT) Investors of May 2, 2016 Lead Plaintiff Deadline in a Newly Filed Class Action

By Nasdaq OMXMar 8, 2016, 1:30 PM UTC